Status:
COMPLETED
Protecting the Corneal Endothelium During Cataract Surgery Using the Anterior Capsule
Lead Sponsor:
Prim. Prof. Dr. Oliver Findl, MBA
Conditions:
Endothelial Cell Loss, Corneal
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Cataract surgery is one of the most frequently performed surgical procedures worldwide. Since the introduction of phacoemulsification to remove the cataractous lens, risk and complication rates of cat...
Eligibility Criteria
Inclusion
- Cataract
- Age 21 and older
- Written informed consent prior to surgery
- Moderate to severe nuclear or mixed cataract
Exclusion
- Corneal pathologies
- Pregnancy
- Patients with an increased surgical risk (i.e. patients with pseudoexfoliation syndrome, patients with the potential risk of intra-operative floppy iris syndrome)
Key Trial Info
Start Date :
March 2 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 5 2018
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03855293
Start Date
March 2 2016
End Date
April 5 2018
Last Update
February 26 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.